The Medicines and Healthcare products Regulatory Agency (MHRA) has extended its dedicated Adverse Drug Reaction (ADR) website for reporting suspected side effects to H1N1 (swine flu) antivirals to now include separate reports about the recently introduced vaccines. Most people who receive the vaccine should not experience any significant side effects.
Read More…
Related Posts
- European Medicines Agency Reaffirms Efficacy And Safety Of H1N1v Pandemic Vaccines
- Swine Flu Vaccine Safety By Dr John Devlin, Deputy Chief Medical Officer, Department Of Health And Children, Ireland
- UNISON Welcomes Swine Flu Vaccination Programme
- Major Nurses Strike And Picket Looms October 30 As RNs To Protest Hospital Gaps In Swine Flu Safety
- Northern Ireland Doctors Welcome Swine Flu Vaccination Programme Announcement- British Medical Association
- Inovio Biomedical, National Microbiology Laboratory, And University Of Pennsylvania To Evaluate Candidate DNA Vaccines Against “Swine” Influenza A
- Pharmacy Swine Flu Trial Moves Into Phase II – Pharmaceutical Society Of Australia
- Swine Flu Update, Thursday, 18th February, 2010, Ireland
- Poor Evidence For Effectiveness Of Influenza Vaccines In Elderly
- Swine Flu Pandemic Weekly Report Thursday 11 February 2010, Wales
- Swine Flu In Pregnancy – What To Look Out For
- Voluntary System Works For Swine Flu Vaccination
- Swine Flu Update, Thursday, 4th February, 2010, Ireland
- Swine Flu Vaccination Available For All Until March 31, Ireland
- Swine Flu Update, Thursday, 28th January, 2010, Ireland
Tags: efficacy, monitoring, programme, running, safety, swine, vaccines
This entry was posted
on Saturday, October 24th, 2009 at 11:10 pm and is filed under Uncategorized.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.
